Healthcare provider profile · identity verified

Ignerys Rosado Maysonet

Emergency Medicine · HUMACAO, PR · NPI 1932278280

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	580	181
Losartan Potassium	Losartan Potassium	471	147
Metformin Hcl	Metformin Hcl	407	118
Famotidine	Famotidine	378	109
Gabapentin	Gabapentin	347	106
Simvastatin	Simvastatin	328	107
Amlodipine Besylate	Amlodipine Besylate	309	102
Pantoprazole Sodium	Pantoprazole Sodium	297	74
Lisinopril	Lisinopril	291	91
Levothyroxine Sodium	Levothyroxine Sodium	286	80
Omeprazole	Omeprazole	251	76
Rosuvastatin Calcium	Rosuvastatin Calcium	242	76
Glimepiride	Glimepiride	182	58
Tamsulosin Hcl	Tamsulosin Hcl	181	59
Temazepam	Temazepam	176	23
Synthroid	Levothyroxine Sodium	153	35
Metoprolol Succinate	Metoprolol Succinate	147	49
Clonazepam	Clonazepam	144	23
Meloxicam	Meloxicam	135	66
Metoprolol Tartrate	Metoprolol Tartrate	131	39
Lorazepam	Lorazepam	120	15
Hydrochlorothiazide	Hydrochlorothiazide	119	42
Buspirone Hcl	Buspirone Hcl	103	27
Montelukast Sodium	Montelukast Sodium	103	34
Ezetimibe	Ezetimibe	101	37
Glipizide	Glipizide	100	34
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	95	31
Baclofen	Baclofen	91	44
Donepezil Hcl	Donepezil Hcl	90	31
Azithromycin	Azithromycin	85	77
Eliquis	Apixaban	83	19
Finasteride	Finasteride	83	27
Irbesartan	Irbesartan	83	22
Pentoxifylline	Pentoxifylline	77	28
Furosemide	Furosemide	68	27
Tizanidine Hcl	Tizanidine Hcl	67	42
Humulin N	Insulin Nph Human Isophane	65	12
Spironolactone	Spironolactone	63	21
Clopidogrel	Clopidogrel Bisulfate	62	25
Memantine Hcl	Memantine Hcl	62	19
Sulindac	Sulindac	62	43
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	59	34
Alendronate Sodium	Alendronate Sodium	57	17
Ciprofloxacin Hcl	Ciprofloxacin Hcl	54	50
Glipizide-Metformin	Glipizide/Metformin Hcl	54	suppressed
Nifedipine Er	Nifedipine	54	16
Candesartan Cilexetil	Candesartan Cilexetil	49	15
Cilostazol	Cilostazol	48	14
Albuterol Sulfate Hfa	Albuterol Sulfate	46	19
Sertraline Hcl	Sertraline Hcl	45	17
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	45	12
Fenofibrate	Fenofibrate,micronized	42	12
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	41	suppressed
Carvedilol	Carvedilol	41	14
Fenofibrate	Fenofibrate	41	16
Meclizine Hcl	Meclizine Hcl	39	20
Doxazosin Mesylate	Doxazosin Mesylate	37	14
Cephalexin	Cephalexin	36	35
Ibuprofen	Ibuprofen	36	14
Lantus	Insulin Glargine,hum.Rec.Anlog	35	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	34	26
Fluticasone Propionate	Fluticasone Propionate	33	14
Naproxen	Naproxen	33	19
Nabumetone	Nabumetone	32	16
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	30	suppressed
Verapamil Er	Verapamil Hcl	29	suppressed
Glipizide Er	Glipizide	28	suppressed
Prednisone	Prednisone	28	18
Tramadol Hcl	Tramadol Hcl	28	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	27	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	26	suppressed
Levetiracetam	Levetiracetam	26	suppressed
Candesartan-Hydrochlorothiazid	Candesartan/Hydrochlorothiazid	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	25	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	25	suppressed
Diclofenac Potassium	Diclofenac Potassium	24	11
Duloxetine Hcl	Duloxetine Hcl	24	suppressed
Latanoprost	Latanoprost	23	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	23	suppressed
Ciclopirox	Ciclopirox	20	17
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	19
Insulin Syringe	Syringe And Needle,insulin,1ml	19	suppressed
Betamethasone Valerate	Betamethasone Valerate	18	11
Gentamicin Sulfate	Gentamicin Sulfate	18	11
Mometasone Furoate	Mometasone Furoate	18	13
Trijardy Xr	Empaglifloz/Linaglip/Metformin	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	16	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	16	suppressed
Raloxifene Hcl	Raloxifene Hcl	16	suppressed
Alprazolam	Alprazolam	15	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Fluconazole	Fluconazole	15	suppressed
Methylprednisolone	Methylprednisolone	15	15
Risperidone	Risperidone	15	suppressed
Sure Comfort	Syring-Needl,disp,insul,0.3 Ml	15	suppressed
Valsartan	Valsartan	15	suppressed
Atenolol	Atenolol	14	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Insulin Lispro	Insulin Lispro	14	suppressed
Lumigan	Bimatoprost	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Trazodone Hcl	Trazodone Hcl	14	suppressed
Citalopram Hbr	Citalopram Hydrobromide	13	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	13	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	13	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	13	suppressed
Sure Comfort	Syringe And Needle,insulin,1ml	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Advocate Syringes	Syringe-Needle,insulin,0.5 Ml	12	suppressed
Amoxicillin	Amoxicillin	12	12
Azelastine Hcl	Azelastine Hcl	12	suppressed
Bethanechol Chloride	Bethanechol Chloride	12	suppressed
Dexamethasone	Dexamethasone	12	12
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Glycopyrrolate	Glycopyrrolate	11	suppressed
Indapamide	Indapamide	11	suppressed
Pregabalin	Pregabalin	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error